Head-to-head
CoreAge Rx vs REMEVi
CoreAge Rx and REMEVi both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxREMEVi
Ranked #27 · Grade C
Best for: Working moms who want to see every plan-length tier before committing and value bilingual (EN/ES) support.
Visit REMEViThe verdict
CoreAge Rx edges out REMEVi on the Rx-Readiness Score, 95 to 66 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
REMEVi is still a genuine option — a genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | REMEVi |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 66/100 · C |
| Overall rank | #1 | #27 |
| Semaglutide | $99/mo | $149-219/mo depending on plan length |
| Tirzepatide | $149/mo | $199-319/mo depending on plan length |
| Coverage | All 50 states | All 50 states + DC |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
REMEVi
Ranked #27 · Grade C
What we like
- All three plan-length tiers for both molecules are visible on the public site, no intake required
- Explicitly states the price never climbs with dose — a real flat-pricing claim, not just a marketing line
- Bilingual (English/Spanish) support with WhatsApp, plus press mentions (AP, USA Today, Fortune, Reuters)
The caveats
- No brand-name (FDA-approved) option
- The oral tablet option's own separate pricing tier wasn't itemized on the pages checked
- No published time-to-first-dose or statement on whether a video visit is required
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and REMEVi against other providers on our shortlist.
Or browse the full comparison hub.